PME.ASX: Preliminary Final Report FY26 (Appendix 4E)

Preliminary Final Report FY26 (Appendix 4E)

Stock	Pro Medicus Ltd (PME.ASX)
Release Time	18 Aug 2026, 9:31 a.m.
Price Sensitive	Yes

This feature provides summaries of price-sensitive announcements for companies followed by users on InvestorPA. The summaries are generated by large language models so please interpret with care.

Pro Medicus Ltd FY26 Preliminary Final Report

Key Points

Revenue increased by 22.9% to A$261.69M
Underlying profit before tax rose 24.2% to A$205.2M
Net profit attributable to members surged 130.3% to A$265.34M
Final dividend increased to 37.0 cents per share

Full Summary

Pro Medicus Ltd's Preliminary Final Report for the financial year ending 30 June 2026 reveals substantial growth in financial performance. The company reported a 22.9% increase in revenue from ordinary activities to A$261.69M. Underlying profit before tax rose by 24.2% to A$205.2M, with fair value movement of other financial assets contributing significantly. The reported profit before tax was A$377.52M, a 131.2% increase from the previous year. Net profit attributable to members surged 130.3% to A$265.34M. The company also increased its dividends, with a final dividend of 37.0 cents per share, up from 30.0 cents in the previous year. The financial statements and detailed results commentary are available in the attached documents.